- Home
- DRH vs IMCR Comparison
DRH vs IMCR Comparison
Compare DRH & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRH
- IMCR
- Stock Information
- Founded
- DRH 2004
- IMCR 2008
- Country
- DRH United States
- IMCR United Kingdom
- Employees
- DRH N/A
- IMCR N/A
- Industry
- DRH Real Estate Investment Trusts
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DRH Real Estate
- IMCR Health Care
- Exchange
- DRH Nasdaq
- IMCR Nasdaq
- Market Cap
- DRH 1.8B
- IMCR 1.7B
- IPO Year
- DRH 2005
- IMCR 2021
- Fundamental
- Price
- DRH $9.14
- IMCR $32.12
- Analyst Decision
- DRH Buy
- IMCR Buy
- Analyst Count
- DRH 6
- IMCR 13
- Target Price
- DRH $10.17
- IMCR $68.73
- AVG Volume (30 Days)
- DRH 1.5M
- IMCR 237.7K
- Earning Date
- DRH 11-07-2024
- IMCR 11-06-2024
- Dividend Yield
- DRH 1.31%
- IMCR N/A
- EPS Growth
- DRH N/A
- IMCR N/A
- EPS
- DRH 0.29
- IMCR N/A
- Revenue
- DRH $1,114,379,000.00
- IMCR $296,312,000.00
- Revenue This Year
- DRH N/A
- IMCR $28.88
- Revenue Next Year
- DRH $2.47
- IMCR $12.61
- P/E Ratio
- DRH $31.96
- IMCR N/A
- Revenue Growth
- DRH 4.50
- IMCR 25.09
- 52 Week Low
- DRH $7.74
- IMCR $29.72
- 52 Week High
- DRH $9.99
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- DRH 56.33
- IMCR 46.91
- Support Level
- DRH $8.76
- IMCR $30.52
- Resistance Level
- DRH $9.44
- IMCR $33.61
- Average True Range (ATR)
- DRH 0.24
- IMCR 1.68
- MACD
- DRH -0.01
- IMCR -0.14
- Stochastic Oscillator
- DRH 63.53
- IMCR 39.00
About DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transient, business transient, and group customers.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.